BIOMAT Database Logo BIOMAT Database Logo

[Pulmonary pressure-flow relationship following pulmonary microembolism: preventive therapy with heparin and acetylsalicylic acid/dipyridamole]. 1977

H Leinberger, and U Bleyl, and U B Brückner, and T Klöss, and M Metzker, and W Saggau, and J Schmier

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D011652 Pulmonary Circulation The circulation of the BLOOD through the LUNGS. Pulmonary Blood Flow,Respiratory Circulation,Circulation, Pulmonary,Circulation, Respiratory,Blood Flow, Pulmonary,Flow, Pulmonary Blood,Pulmonary Blood Flows
D011655 Pulmonary Embolism Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS. Pulmonary Thromboembolism,Thromboembolism, Pulmonary,Embolism, Pulmonary,Embolisms, Pulmonary,Pulmonary Embolisms,Pulmonary Thromboembolisms,Thromboembolisms, Pulmonary
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002302 Cardiac Output The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat). Cardiac Outputs,Output, Cardiac,Outputs, Cardiac
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004176 Dipyridamole A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) Antistenocardin,Apo-Dipyridamole,Cerebrovase,Cléridium,Curantil,Curantyl,Dipyramidole,Kurantil,Miosen,Novo-Dipiradol,Persantin,Persantine,Apo Dipyridamole,Novo Dipiradol
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen

Related Publications

H Leinberger, and U Bleyl, and U B Brückner, and T Klöss, and M Metzker, and W Saggau, and J Schmier
Reocclusion prophylaxis with dipyridamole combined with acetylsalicylic acid following PTA.
April 1990, Angiology,
H Leinberger, and U Bleyl, and U B Brückner, and T Klöss, and M Metzker, and W Saggau, and J Schmier
The treatment of rejection. A trial of acetylsalicylic acid, dipyridamole, and heparin.
September 1975, Transplantation,
H Leinberger, and U Bleyl, and U B Brückner, and T Klöss, and M Metzker, and W Saggau, and J Schmier
[Combination of acetylsalicylic acid with dipyridamole is better than acetylsalicylic acid monotherapy].
November 2006, Medizinische Monatsschrift fur Pharmazeuten,
H Leinberger, and U Bleyl, and U B Brückner, and T Klöss, and M Metzker, and W Saggau, and J Schmier
Pulmonary embolism in a homocystinuric patient during treatment with dipyridamole and acetylsalicylic acid.
September 1978, The New England journal of medicine,
H Leinberger, and U Bleyl, and U B Brückner, and T Klöss, and M Metzker, and W Saggau, and J Schmier
Pharmacokinetic interaction of acetylsalicylic acid and dipyridamole.
March 1985, British journal of clinical pharmacology,
H Leinberger, and U Bleyl, and U B Brückner, and T Klöss, and M Metzker, and W Saggau, and J Schmier
Acetylsalicylic acid + extended-release dipyridamole combination therapy for secondary stroke prevention.
July 2008, Clinical therapeutics,
H Leinberger, and U Bleyl, and U B Brückner, and T Klöss, and M Metzker, and W Saggau, and J Schmier
[Platelet function in patients with acute myocardial infarct following administration of acetylsalicylic acid and dipyridamole].
February 1979, Polskie Archiwum Medycyny Wewnetrznej,
H Leinberger, and U Bleyl, and U B Brückner, and T Klöss, and M Metzker, and W Saggau, and J Schmier
Pulmonary vascular pressure-flow relationship in canine oleic acid pulmonary edema.
December 1986, The American journal of physiology,
H Leinberger, and U Bleyl, and U B Brückner, and T Klöss, and M Metzker, and W Saggau, and J Schmier
[Prevention of vascular complications following cerebral ischemia of arterial origin; the ESPRIT trial: mild anticoagulant therapy, combination treatment with acetylsalicylic acid plus dipyridamole or treatment with acetylsalicylic acid alone?].
February 1998, Nederlands tijdschrift voor geneeskunde,
H Leinberger, and U Bleyl, and U B Brückner, and T Klöss, and M Metzker, and W Saggau, and J Schmier
[Secondary prevention after ischemic cerebral infarct. The ESPRIT Study: low dose anticoagulation, combined therapy with acetylsalicylic acid/dipyridamole or monotherapy with acetylsalicylic acid?].
April 1999, Der Nervenarzt,
Copied contents to your clipboard!